Mays Cancer Center at UT Health SA

UT Health SA 梅斯癌症中心

基本信息

  • 批准号:
    10025087
  • 负责人:
  • 金额:
    $ 26.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary—Biostatistics and Bioinformatics Shared Resource The purpose of the Biostatistics and Bioinformatics Shared Resource (BBSR) is to provide biostatistics and bioinformatics resources to the Mays Cancer Center (MCC) at the University of Texas Health San Antonio (UT Health SA). The BBSR is comprised of faculty and staff along with high-performance computing resources and genomic and biostatistical data resources that have been in operation since 2001.The BBSR provides consolidated biostatistical and bioinformatics support and expertise; state-of-the-art data science tools for design and development of basic, clinical, and population-based studies; and data-focused education and training to MCC members and trainees. The BBSR is managed by the MCC. It is physically housed in three locations including 3,669 sq.ft. in the Administration Building on the Long School of Medicine (LSOM) campus, 1,321 sq.ft. in the MCC building, and 2,000 sq.ft. in the Greehey Children’s Cancer Research Institute (GCCRI). There are a total of five supported faculty and three staff members. The BBSR maintains a close relationship with the Next- Generation Sequencing Shared Resource (NGSSR) for study/experimental design as well as integrating data from clinical and population-based research investigations with high-throughput data sources. Yidong Chen, Ph.D. (PSP) is the Director of the BBSR and the co-Director is Jonathan Gelfond, M.D., Ph.D. (EDT). This centralized core provides flexible, open accountable, cost-efficient access to biostatistics and bioinformatics services essential to the basic, translational, clinical and population-based research across all three programs of the MCC. The BBSR emphasizes support of new research investigations. Support services are provided in a consistent manner to be responsive to the needs of individual researchers while optimizing the use of our shared biostatistical and bioinformatics resources across the entire Cancer Center. Services that are provided include: protocol development; statistical and bioinformatics study/experiment design and planning; bioinformatics and statistical analysis; statistical monitoring; and performance evaluation. The BBSR has co-authored 64 cancer- related publications during the last reporting period. In 2018, the BBSR worked with 30 MCC members with peer-reviewed cancer-related funding, 45% of the total number of users. BBSR usage is anticipated to grow with expanding proteomic profiling and high-throughput sequencing and screening techniques. New instruments in the NGSSR for single-cell data analysis, adoption of data-independent acquisition methods in the MSSR, and more MCC members using CRISPR pooled screening techniques will offer new opportunities to collaborate across the Shared Resources. Use of biostatistical services is also expected to increase by about 5% per year based on requests from 2014-2018 and new services offered.
项目摘要-生物统计学与生物信息学共享资源

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yidong Chen其他文献

Yidong Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yidong Chen', 18)}}的其他基金

Mays Cancer Center at UT Health SA
UT Health SA 梅斯癌症中心
  • 批准号:
    10460433
  • 财政年份:
    1997
  • 资助金额:
    $ 26.81万
  • 项目类别:
Mays Cancer Center at UT Health SA
UT Health SA 梅斯癌症中心
  • 批准号:
    10653906
  • 财政年份:
    1997
  • 资助金额:
    $ 26.81万
  • 项目类别:
Mays Cancer Center at UT Health SA
UT Health SA 梅斯癌症中心
  • 批准号:
    10237953
  • 财政年份:
    1997
  • 资助金额:
    $ 26.81万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了